Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 285Lymphoma 201Lymphoma, Large B-Cell, Diffuse 167Sarcoma 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Hodgkin Disease 85Lymphoma, Non-Hodgkin 78Burkitt Lymphoma 67Lymphoma, Follicular 61Leukemia 58Ovarian Neoplasms 50Neoplasms 50Triple Negative Breast Neoplasms 49Lymphoma, Mantle-Cell 48Multiple Myeloma 47Neuroblastoma 44Carcinoma, Hepatocellular 44Neoplasm Metastasis 41Lymphoma, B-Cell 33Lymphoma, Large-Cell, Anaplastic 31Lymphoma, T-Cell, Peripheral 27Recurrence 26Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Osteosarcoma 25Liposarcoma 25Leiomyosarcoma 25Urinary Bladder Neoplasms 23Lymphoma, Large-Cell, Immunoblastic 23Liver Neoplasms 22Endometrial Neoplasms 21

Interventions

Vancomycin 4pegfilgrastim 3Cefepime 3trametinib 2liposomal amphotericin B 2dabrafenib 2Piperacillin, Tazobactam Drug Combination 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Caspofungin 2ofatumumab 1ceftobiprole medocaril 1Teicoplanin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Povidone-Iodine 1Piperacillin 1Moxifloxacin 1Metformin 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fever × Doxorubicin × Clear all
NCT00115414 2008-08-01

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Amgen

Phase 2 Completed
Breast

Breast Neoplasms, Fever, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡